$6.21
+1.5%Strata Critical Medical, Inc. provides time critical logistics solutions and specialized medical services to healthcare providers across the United States. The company operates as both an air and ground transporter of human organs for transplant. The company was formerly known as Blade Air Mobility, Inc. and change its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
Chief Accounting Officer
Chief Executive Officer & Director
Compensation
$1,609,071
Chief Executive Officer of Trinity
Chief Financial Officer & Head of Corporate Development
Compensation
$931,616
President, General Counsel & Corporate Secretary
Compensation
$978,910
Vice President of Investor Relations & Strategic Finance
During the last 12 months, insiders have purchased $98K and sold $5.15M worth of SRTA shares, resulting in $5.05M of net selling activity.
0
0.00
65.2K
382.27K
-382K
-$382K
17.0K
76.04K
0
0.00
+76K
+$76K
5.0K
21.82K
435.9K
1.56M
-1.5M
-$1.54M
0
0.00
1.1M
3.21M
-3.2M
-$3.21M
Heyburn William A.
Director, Officer: Co-Ceo And Cfo
$76K
Lauck Andrew
Director
$22K
Tomkiel Melissa M.
Director, Officer: Co-Ceo And General Counsel
$1.80M
Heyburn William A.
Director, Officer: Co-Ceo And Cfo
$1.72M
Wiesenthal Robert S
Director, 10 Percent Owner, Officer: Chief Executive Officer
$940K
Cohen Amir
Officer: Chief Accounting Officer
$576K
Love Reginald
Director
$96K
Strong bearish signal with $5.05M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
5 insider sellers vs. 2 buyers. Widespread selling across multiple insiders may signal concerns.
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
SRTA - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 14, 2026 | May 28, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | March 24, 2025 | May 06, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | March 22, 2024 | May 02, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | March 30, 2023 | May 09, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | March 22, 2022 | May 04, 2022 | 2022 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.